JAN 22, 2020 6:55 AM PST

Biosignatures detect TB infections months before symptoms appear

WRITTEN BY: Tara Fernandez

What if there was a test that could detect tuberculosis up to six months before symptoms appear? Researchers at the University of College London think a predictive diagnostic tool like this might soon become a reality, thanks to their work looking into gene expression patterns in the blood.

Tuberculosis, or TB, is caused by a slow-growing bacteria called Mycobacterium tuberculosis. This infectious pathogen thrives in oxygen-rich areas of the body, particularly the lungs, and is spread as coughs or sneezes propel it into the air. Immunocompromised people and those who live and work in crowded places such as healthcare facilities and prisons are especially at risk of contracting TB.

 

 

Diagnosis typically involves a tuberculin skin test to identify TB’s asymptomatic latent version. On the other hand, patients presenting with a persistent cough, fatigue, swelling of the lymph nodes or shortness of breath are likely to have the active form. This group is typically subjected to chest X-rays and sputum tests before physicians can make a positive TB diagnosis.

Globally, TB infections are among the top 10 causes of death, with the World Health Organization estimating that 10 million people contracted the disease in 2018. While it’s a condition that is preventable and treatable, a more accessible and reliable diagnostic remains to be developed.

Lead researcher Rishi Gupta hypothesized that mRNA biosignatures in patient blood samples could hold early, presymptomatic diagnostic clues, making them more valuable than traditional sputum samples. In research published in The Lancet Respiratory Medicine, Gupta and colleagues performed their analysis on genetic data collected from over 1000 blood samples, obtained from infected and healthy residents of South Africa, Ethiopia, The Gambia, and the UK. 

The team narrowed down potential mRNA candidates to a panel of 17 genes, which appeared to be consistently differentially expressed in TB-infected people over healthy controls. 

Speaking on the significance of their findings, Gupta said: "The emergence of gene expression signature tests, which can aid diagnosis and early treatment, provides real hope for the management of infectious diseases. In this study we identify multiple signatures to identify the onset of tuberculosis, which is extremely encouraging, potentially providing multiple targets for early detection.”

This is the first step towards a diagnostic blood test that could curtail the spread of TB, enable early antibiotic treatment interventions and prevent unnecessary deaths. 


Sources: Eurekalert, The Lancet Respiratory Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JAN 14, 2021
Cardiology
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
JAN 14, 2021
Cortisol in Your Hair Could Predict Your Risk of Heart Attack
The everyday tracking of health has become far easier these days with the advent of fitness watches and other technology ...
JAN 24, 2021
Genetics & Genomics
Rare Neurodevelopment Disorder LINKED is IDed
JAN 24, 2021
Rare Neurodevelopment Disorder LINKED is IDed
Scientists have now characterized a genetic disorder called linkage-specific-deubiquitylation-deficiency-induced embryon ...
JAN 28, 2021
Clinical & Molecular DX
A $5 Test Detects Colon Cancer Before Symptoms Appear
JAN 28, 2021
A $5 Test Detects Colon Cancer Before Symptoms Appear
Researchers at the University of Exeter have found that their new colorectal cancer diagnostic test effectively catches ...
MAR 23, 2021
Clinical & Molecular DX
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
MAR 23, 2021
AI Test Distinguishes Cancer Cells From Healthy Ones Based on Acidity Levels
Researchers have developed a new way of differentiating cancer cells from healthy ones—by how acidic they are. The ...
MAR 30, 2021
Clinical & Molecular DX
The COVID Eye of the Tiger
MAR 30, 2021
The COVID Eye of the Tiger
A wearable COVID screening device that uses light sensors to check for signs of infection has gotten FDA regulatory clea ...
APR 19, 2021
Genetics & Genomics
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
APR 19, 2021
Better Disease Risk Predictions May Come From Ancestry Data, Not Race
Researchers have suggested that it's time for medicine to move away from demographic labels that are too narrow to captu ...
Loading Comments...